​​​​​

  • Risankizumab: an anti-IL-23 antibody for the treatment of psoriasis

    Risankizumab is currently in late-stage development for use in the treatment of moderate-to-severe plaque psoriasis.

  • Recent update to patellofemoral pain guidelines

    New recommendations have been published regarding the management of patellofemoral pain.

  • Visit to chiropractor leads to diagnosis of a brain cyst

    A woman's odd symptoms following neck manipulation by a chiropractor revealed a dormant arachnoid cyst.

Our people are at the forefront of health care

Why Baylor Scott & White Health

We’ve created a transformative model for the health care industry that eliminates waste, improves coordination of care and helps us better manage chronic disease.

Medical Education

Baylor Scott & White has both clinical and research campuses for the Texas A&M Health Science Center (HSC) College of Medicine. In addition, we are an accredited provider for the Accreditation Council for Continuing Medical Education (ACCME).

Our Departments

Our extensive network of 48 hospitals and more than 900 patient care sites – including specialized centers, institutes and regional clinics – offers your patients a full range of medical expertise.

Innovation with a commitment to every patient

Brugada ST elevation masquerading as ST elevation myocardial infarction

We describe the initial diagnosis in a man who presented with fevers and electrocardiographic changes.

Third annual IBD Center conference

Sign up early for this CME opportunity designed to review the current state of the art and outlook for mechanism-based IBD therapies.

Type 2 diabetes treatment study

This study compares how well Insulin Aspart or Novolg works and how safe they are in people with Type 2 diabetes.